Texas Retina Associates Announces the Retirement of David Callanan, MD
It is with mixed emotions that we announce the retirement of David Callanan, MD, from Texas Retina Associates effective June 30, 2022. He has been caring for patients at our practice since
read more
Dr. Abbey Spoke About Complications of a Compounded Medication Used in “Dropless” Cataract Surgery at the Vit-Buckle Society (VBS) Annual Meeting
Texas Retina Associates’ Ashkan M. Abbey, MD, presented “Complications of Compounded Moxifloxacin-Triamcinolone” at the 10th Annual Meeting of the Vit-Buckle Society (VBS) held March 24 – 26, 2022, in Las Vegas. He
read more
Dr. Abbey to Speak at Upcoming Retina World Congress Medical Education Event
On October 24, 2021, Texas Retina Associates’ Ashkan M. Abbey, MD, will serve on a distinguished panel of presenters from across the country for a Retina World Congress continuing medical education (CME)
read more
Ashkan Abbey, MD, Publishes Article Summarizing Highlights from American Academy of Ophthalmology Retina 2019 Subspecialty Day
Texas Retina Associates’ Ashkan Abbey, MD, recently published an article in the current issue of Retina Specialist that summarized the findings of five compelling clinical trial presentations from the American Academy of
read more
David Callanan, MD, Presented Uveitis Clinical Trial Results at American Society of Retina Specialists 2019 Annual Meeting
Texas Retina Associates’ David Callanan, MD, presented the results of a clinical trial on a promising new treatment for chronic posterior segment uveitis at the American Society of Retina Specialists (ASRS) 2019
read more
Ashkan Abbey, MD, Publishes Article on Key Retina Research Findings Presented at ARVO Meeting
Texas Retina Associates’ Ashkan Abbey, MD, serves on the editorial board of Retina Specialist, a medical journal focused on the latest advances in the diagnosis, medical management and surgical treatment of diseases
read more
Clinical Trials Help Uncover New Sight-Saving Treatment Options
At Texas Retina Associates, our physicians are committed to continually improving care for our patients, and a big part of that involves conducting ongoing research of potential new sight-saving retina treatments. Clinical
read more